Abstract
Benign tumors of the eyelid include a variety of nonpigmented and pigmented epidermal tumors (arising from squamous or melanocytic cells), adnexal tumors (Chap. 4), and stromal tumors (Chap. 5). Important to note is that not all clinically pigmented lesions are melanocytic, since squamous cells can pick up melanin pigment, thus giving a pigmented appearance to a lesion. The benign epidermal tumors of the eyelid are similar to those observed in the other sun-exposed areas of the skin, but they may also include conjunctival tumors as well. Some of these tumors represent manifestations of systemic disease (Chap. 12). A classification of the epidermal eyelid tumors is presented in Table 3.1. Only the description of the most common and frequently observed benign tumors, along with their corresponding premalignant lesions and tumorlike nonneoplastic lesions are included in this chapter.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Font RL. Eyelids and lacrimal drainage system. In: Spencer WH, editor. Ophthalmic pathology. An atlas and textbook. 4th ed. Philadelphia: WB Saunders; 1996. p. 2229–32.
Rosai J. Rosai and Ackerman’s surgical pathology. 10th ed. New York: Mosby Elsevier; 2011. p. 129–213.
Boniuk M, Zimmerman LE. Eyelid tumors with reference to lesions confused with squamous cell carcinoma. II. Inverted follicular keratosis. Arch Ophthalmol. 1963;69:698–707.
Brinster NK, Liu V, Diwan AH, McKee PH. High yield pathology: dermatopathology. Philadelphia: Saunders Elsevier; 2011. p. 365–80.
Grossniklaus HE, Wojno TH, Yanoff M, Font RL. Invasive keratoacanthoma of the eyelid and ocular adnexa. Ophthalmology. 1996;103:937–41.
Leibovitch I, Huilgol SC, James CL, Hsuan JD, Davis G, Selva D. Periocular keratoacanthoma: can we always rely on the clinical diagnosis? Br J Ophthalmol. 2005;89:1201–4.
Donaldson MJ, Sullivan TJ, Whitehead KJ, Williamson RM. Periocular keratoacanthoma: clinical features, pathology, and management. Ophthalmology. 2003;110:1403–7.
Mencia-Gutierrez E, Gutierrez-Diaz E, Redondo-Marcos I, Ricoy JR, Garcia-Torre JP. Cutaneous horns of the eyelid: a clinicopathological study of 48 cases. J Cutan Pathol. 2004;31:539–43.
Vujevich JJ, Mancini AJ. The epidermal nevus syndromes: multisystem disorders. J Am Acad Dermatol. 2004;50:957–61.
Miller CJ, Ioffreda MD, Billingsley EM. Sebaceous carcinoma, basal cell carcinoma, trichoadenoma, trichoblastoma, and syringocystadenoma papilliferum arising within a nevus sebaceus. Dermatol Surg. 2004;30:1546–9.
Fu W, Cockerell CJ. The actinic (solar) keratosis: a 21st-century perspective. Arch Dermatol. 2003;139:66–70.
Lebwohl M. Actinic keratosis: epidemiology and progression to squamous cell carcinoma. Br J Dermatol. 2003;149 Suppl 66:31–3.
Mittelbronn MA, Mullins DL, Ramos-Caro FA, Flowers FP. Frequency of pre-existing actinic keratosis in cutaneous squamous cell carcinoma. Int J Dermatol. 1998;37:677–81.
Marks R, Rennie G, Selwood TS. Malignant transformation of solar keratoses to squamous cell carcinoma. Lancet. 1988;1:795–7.
Person JR. An actinic keratosis is neither malignant nor premalignant: it is an initiated tumor. J Am Acad Dermatol. 2003;48:637–8.
Anwar J, Wrone DA, Kimyai-Asadi A, Alam M. The development of actinic keratosis into invasive squamous cell carcinoma: evidence and evolving classification schemes. Clin Dermatol. 2004;22:189–96.
Lober BA, Fenske NA. Optimum treatment strategies for actinic keratosis (intraepidermal squamous cell carcinoma). Am J Clin Dermatol. 2004;5:395–401.
Pirard D, Vereecken P, Melot C, Heenen M. Three percent diclofenac in 2.5% hyaluronan gel in the treatment of actinic keratoses: a meta-analysis of the recent studies. Arch Dermatol Res. 2005;297:185–9.
Krengel S. Nevogenesis–new thoughts regarding a classical problem. Am J Dermatopathol. 2005;27:456–65.
Tannous ZS, Mihm Jr MC, Sober AJ, Duncan LM. Congenital melanocytic nevi: clinical and histopathologic features, risk of melanoma, and clinical management. J Am Acad Dermatol. 2005;52:197–203.
Kopf AW, Bart RS, Hennessey P. Congenital nevocytic nevi and malignant melanomas. J Am Acad Dermatol. 1979;1:123–30.
Watt AJ, Kotsis SV, Chung KC. Risk of melanoma arising in large congenital melanocytic nevi: a systematic review. Plast Reconstr Surg. 2004;113:1968–74.
Krengel S, Hauschild A, Schafer T. Melanoma risk in congenital melanocytic naevi: a systematic review. Br J Dermatol. 2006;155:1–8.
Anonymous. Consensus conference: precursors to malignant melanoma. JAMA 1984;251:1864–6.
Mark GJ, Mihm MC, Liteplo MG, Reed RJ, Clark WH. Congenital melanocytic nevi of the small and garment type. Clinical, histologic, and ultrastructural studies. Hum Pathol. 1973;4:395–418.
Pollock PM, Harper UL, Hansen KS, Yudt LM, Stark M, Robbins CM, Moses TY, Hostetter G, Wagner U, Kakareka J, Salem G, Pohida T, Heenan P, Duray P, Kallioniemi O, Hayward NK, Trent JM, Meltzer PS. High frequency of BRAF mutations in nevi. Nat Genet. 2003;33:19–20.
Margo CE, Rabinowicz IM, Habal MB. Periocular congenital melanocytic nevi. J Pediatr Ophthalmol Strabismus. 1986;23:222–6.
Makkar HS, Frieden IJ. Neurocutaneous melanosis. Semin Cutan Med Surg. 2004;23:138–44.
McDonnell PJ, Mayou BJ. Congenital divided naevus of the eyelids. Br J Ophthalmol. 1988;72:198–201.
Hamming N. Anatomy and embryology of the eyelids: a review with special reference to the development of divided nevi. Pediatr Dermatol. 1983;1:51–8.
Nawa Y, Hara Y, Saishin M. Conjunctival melanoma associated with extensive congenital conjunctival nevus and split nevus of eyelid. Arch Ophthalmol. 1999;117:269–71.
Ribuffo D, Cavalieri L, Sonnino M, et al. Divided nevus of the eyelid: a case report. Ophthal Plast Reconstr Surg. 1996;12:186–9.
Folberg R, Jakobiec FA, Bernardino VB, Iwamoto T. Benign conjunctival melanocytic lesions. Clinicopathologic features. Ophthalmology. 1989;96:436–61.
Mones JM, Ackerman AB. “Atypical” blue nevus, “malignant” blue nevus, and “metastasizing” blue nevus: a critique in historical perspective of three concepts flawed fatally. Am J Dermatopathol. 2004;26:407–30.
Demirci H, Shields CL, Shields JA, Eagle Jr RC. Malignant melanoma arising from unusual conjunctival blue nevus. Arch Ophthalmol. 2000;118:1581–4.
Gunduz K, Shields JA, Shields CL, Eagle Jr RC. Periorbital cellular blue nevus leading to orbitopalpebral and intracranial melanoma. Ophthalmology. 1998;105:2046–50.
Loffler KU, Witschel H. Primary malignant melanoma of the orbit arising in a cellular blue naevus. Br J Ophthalmol. 1989;73:388–93.
Odashiro AN, Arthurs B, Pereira PR, Filho JP, Belfort E, Burnier Jr MN. Primary orbital melanoma associated with a blue nevus. Ophthal Plast Reconstr Surg. 2005;21:247–8.
Van Raamsdonk CK, Bezrookove V, Green G, Bauer J, Gaugler L, O’Brien JM, Simpson EM, Barsh GS, Bastian BC. Frequent somatic mutations of GNAQ in uveal melanoma and blue nevi. Nature. 2009;457:599–602.
Singh AD, De Potter P, Fijal BA, Shields CL, Shields JA, Elston RC. Lifetime prevalence of uveal melanoma in white patients with oculo(dermal) melanocytosis. Ophthalmology. 1998;105:195–8.
Patel BC, Egan CA, Lucius RW, Gerwels JW, Mamalis N, Anderson RL. Cutaneous malignant melanoma and oculodermal melanocytosis (nevus of Ota): report of a case and review of the literature. J Am Acad Dermatol. 1998;38:862–5.
Wiecker TS, Luther H, Buettner P, Bauer J, Garbe C. Moderate sun exposure and nevus counts in parents are associated with development of melanocytic nevi in childhood: a risk factor study in 1,812 kindergarten children. Cancer. 2003;97:628–38.
MacLennan R, Kelly JW, Rivers JK, Harrison SL. The Eastern Australian Childhood Nevus Study: site differences in density and size of melanocytic nevi in relation to latitude and phenotype. J Am Acad Dermatol. 2003;48:367–75.
Winkelmann RK, Rocha G. The dermal nevus and statistics. An evaluation of 1,200 pigmented lesions. Arch Dermatol. 1962;86:310–5.
Spitz S. Melanoma of the childhood. Am J Pathol. 1948;24:591–609.
Hiscott P, Seitz B, Naumann GO. Epithelioid cell Spitz nevus of the eyelid. Am J Ophthalmol. 1998;126:735–7.
Piepkorn M. The Spitz nevus is melanoma. Am J Dermatopathol. 2005;27:367–9.
Smith KJ, Skleton HG, Lupton GP, Graham JH. spindle cell and epithelioid cell nevi with atypia and metastasis (malignant Spitz nevus). Am J Surg Pathol. 1989;13:931–9.
Weedon D. Borderline melanocytic tumors. J Cutan Pathol. 1985;12:266–70.
Goldes J, Holmes S, Satz M, Cich J, Dehner L. Melanoma masquerading as Spitz nevus following acute lymphoblastic leukaemia. Pediatr Dermatol. 1984;1:295–8.
Marghoob AA. The dangers of atypical mole (dysplastic nevus) syndrome. Teaching at-risk patients to protect themselves from melanoma. Postgrad Med. 1999;105:147–8, 151–2, 154 passim.
Salopek TG. The dilemma of the dysplastic nevus. Dermatol Clin. 2002;20:617–28.
Clark Jr WH, Reimer RR, Greene M, Ainsworth AM, Mastrangelo MJ. Origin of familial malignant melanomas from heritable melanocytic lesions: ‘The B-K Mole syndrome’. Arch Dermatol. 1978;114:732–8.
NIH. NIH Consensus conference. Diagnosis and treatment of early melanoma. JAMA. 1992;268:1314–9.
de Snoo FA, Bergman W, Gruis NA. Familial melanoma: a complex disorder leading to controversy on DNA testing. Fam Cancer. 2003;2:109–16.
Wetherington RW, Cockerell CJ. The “dysplastic” nevus: an update at 25 years. Adv Dermatol. 2003;19:237–48.
Damato B, Singh D. Clinical Opthalmic Oncology: Uveal Tumors. Berlin: Springer (in press).
Stevenson O, Ahmed I. Lentigo maligna: prognosis and treatment options. Am J Clin Dermatol. 2005;6:151–64.
Hutchinson J. Notes on the cancerous process and on new growths in general. Arch Surg. 1890;2:83–6.
Klaus W, Allen JR, Dick S, Fitzpatrick TB. Fitzpatrick’s color atlas and synopsis of clinical dermatology. 5th ed. New York: The McGraw-Hill Companies; 2005.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Schoenfield, L., Singh, A.D. (2014). Benign Squamous and Melanocytic Tumors. In: Pe'er, J., Singh, A. (eds) Clinical Ophthalmic Oncology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-38336-6_3
Download citation
DOI: https://doi.org/10.1007/978-3-642-38336-6_3
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-38335-9
Online ISBN: 978-3-642-38336-6
eBook Packages: MedicineMedicine (R0)